BNLI Randomised trial of Radiation dose in Non-Hodgkin's Lymphoma (NHL)

ISRCTN ISRCTN71826974
DOI https://doi.org/10.1186/ISRCTN71826974
Secondary identifying numbers RADIATION
Submission date
19/08/2002
Registration date
19/08/2002
Last edited
18/10/2018
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr - -
Scientific

UKCCCR Register Co-ordinator
MRC Clinical Trials Unit
222 Euston Road
London
NW1 2DA
United Kingdom

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleBNLI Randomised trial of Radiation dose in Non-Hodgkin's Lymphoma (NHL)
Study objectivesNot provided at time of registration
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedLymphoma (non-Hodgkin's)
InterventionStandard radiotherapy versus low dose radiotherapy
Intervention typeOther
Primary outcome measureNot provided at time of registration
Secondary outcome measuresNot provided at time of registration
Overall study start date30/04/1997
Completion date31/12/2005

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants1000
Key inclusion criteria1. Any patient receiving local radiotherapy (RT) where the aim of the treatment is local control of that lymphoma, whether as radical treatment of Stage I disease, consolidation therapy after chemotherapy or palliation
2. Histological diagnosis of NHL
3. Aged 18 years or over
4. Able to give informed consent
Key exclusion criteriaNot provided at time of registration
Date of first enrolment30/04/1997
Date of final enrolment31/12/2005

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

MRC Clinical Trials Unit
London
NW1 2DA
United Kingdom

Sponsor information

British National Lymphoma Investigation (BNLI) (UK)
Charity

CRC and UCL Cancer Trials Centre
222 Euston Road
London
NW1 2DA
United Kingdom

Phone +44 (0)20 7679 8060
Email bnli@ctc.ucl.ac.uk
Website http://www.bnli.ucl.ac.uk

Funders

Funder type

Charity

British National Lymphoma Investigation (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Plain English results No Yes

Editorial Notes

18/10/2018: Cancer Research UK lay results summary link added to Results (plain English)
11/01/2016: no publications found on PubMed.